Navarro et al. [18,19] evaluated the PC system in subjects with Behçet’s disease and demonstrated that such patients who develop a VTE had significantly lower levels of plasma APC, PC inhibitor, and thrombomodulin than those patients who did not. This evidence concerns the gene APC and Behcet disease.